RSS

Japan's Ministry of Health, Labour and Welfare (MHLW)

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved AstraZeneca’s Tagrisso (osimertinib) as a first-line treatment of patients with inoperable or recurrent epidermal growth factor mutation-positive non-small cell lung cancer more

News

The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. more

News

Recipharm was informed on 20 September 2013 by the R&D-based pharmaceutical company Kyowa Hakko Kirin Co. Ltd. that the Abstral sublingual (under the tongue) tablet has been approved for manufacturing and marketing by Japan's Ministry of Health... more

Technology